Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative

Authors

Deepa Jagtap, Wayne State University
Carol A. Rosenberg, NorthShore University Health System, Evanston, IL
Lisa W. Martin, George Washington UniversityFollow
Mary Pettinger, Fred Hutchinson Cancer Research Center, Seattle, WA
Janardan Khandekar, NorthShore University Health System, Evanston, IL
Dorothy Lane, Stony Brook University
Ira Ockene, University of Massachusetts
Michael S. Simon, Wayne State UniversityFollow

Document Type

Journal Article

Publication Date

10-15-2012

Journal

Cancer

Volume

Volume 118, Issue 20

Inclusive Pages

5124-5131

Keywords

Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects; Melanoma--chemically induced; Skin Neoplasms--chemically induced

Comments

PMCID: PMC3889164 [Available on 2014/10/1]

APA Citation

Jagtap, D., Rosenberg, C. A., Martin, L. W., Pettinger, M., Khandekar, J., Lane, D., Ockene, I., Simon, M. S. (2012). Prospective analysis of association between use of statins and melanoma risk in the women's health initiative. Cancer, 118(20), 5124-5131.

Peer Reviewed

1